SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Lu Jianliang)
 

Sökning: WFRF:(Lu Jianliang) > (2007-2009) > 3-(4-Chloro-2-morph...

  • Gehlert, Donald R.Eli Lilly and Company, Indianapolis, IN, USA (författare)

3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine : a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism

  • Artikel/kapitelEngelska2007

Förlag, utgivningsår, omfång ...

  • Society for Neuroscience,2007
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:liu-101855
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-101855URI
  • https://doi.org/10.1523/JNEUROSCI.4985-06.2007DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • We describe a novel corticotropin-releasing factor receptor 1 (CRF1) antagonist with advantageous properties for clinical development, and its in vivo activity in preclinical alcoholism models. 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine (MTIP) inhibited 125I-sauvagine binding to rat pituitary membranes and cloned human CRF1 with subnanomolar affinities, with no detectable activity at the CRF2 receptor or other common drug targets. After oral administration to rats, MTIP inhibited 125I-sauvagine binding to rat cerebellar membranes ex vivo with an ED50 of approximately 1.3 mg/kg and an oral bioavailability of 91.1%. Compared with R121919 (2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylamino-pyrazolo[1,5-a]pyrimidine) and CP154526 (N-butyl-N-ethyl-4,9-dimethyl-7-(2,4,6-trimethylphenyl)-3,5,7-triazabicyclo[4.3.0]nona-2,4,8,10-tetraen-2-amine), MTIP had a markedly reduced volume of distribution and clearance. Neither open-field activity nor baseline exploration of an elevated plus-maze was affected by MTIP (1-10 mg/kg). In contrast, MTIP dose-dependently reversed anxiogenic effects of withdrawal from a 3 g/kg alcohol dose. Similarly, MTIP blocked excessive alcohol self-administration in Wistar rats with a history of dependence, and in a genetic model of high alcohol preference, the msP rat, at doses that had no effect in nondependent Wistar rats. Also, MTIP blocked reinstatement of stress-induced alcohol seeking both in postdependent and in genetically selected msP animals, again at doses that were ineffective in nondependent Wistar rats. Based on these findings, MTIP is a promising candidate for treatment of alcohol dependence.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Cippitelli, AndreaNational Institute on Alcohol Abuse and Alcoholism, NIH; Bethesda, MD, USA (författare)
  • Thorsell, AnnikaNational Institute on Alcohol Abuse and Alcoholism, NIH; Bethesda, MD, USA(Swepub:liu)annth96 (författare)
  • Lê, Anh DzungUniversity of Toronto, Canada (författare)
  • Hipskind, Philip AEli Lilly and Company, Indianapolis, IN, USA (författare)
  • Hamdouchi, ChafiqEli Lilly and Company, Indianapolis, IN, USA (författare)
  • Lu, JianliangEli Lilly and Company, Indianapolis, IN, USA (författare)
  • Hembre, Erik J.Eli Lilly and Company, Indianapolis, IN, USA (författare)
  • Cramer, JeffreyEli Lilly and Company, Indianapolis, IN, USA (författare)
  • Song, MinEli Lilly and Company, Indianapolis, IN, USA (författare)
  • McKinzie, DavidEli Lilly and Company, Indianapolis, IN, USA (författare)
  • Morin, MichelleEli Lilly and Company, Indianapolis, IN, USA (författare)
  • Ciccocioppo, RobertoUniversity of Camerino, Italy (författare)
  • Heilig, MarkusNational Institute on Alcohol Abuse and Alcoholism, NIH; Bethesda, MD, USA(Swepub:liu)marhe41 (författare)
  • Eli Lilly and Company, Indianapolis, IN, USANational Institute on Alcohol Abuse and Alcoholism, NIH; Bethesda, MD, USA (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Journal of Neuroscience: Society for Neuroscience27:10, s. 2718-27260270-64741529-2401

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy